Catégorie
Paclitaxel
Numéro CAS
Paclitaxel STD-33069-62-4: IMP-A-173101-54-7: IMP-G-78432-77-6: IMP-I-2157462-42-3: IMP-L-92950-39-5
Formule moléculaire
Paclitaxel STD-C47H51NO14: IMP-A-C45H53NO14: IMP-G-C45H49NO13: IMP-I-C61H62N2O16: IMP-L-C49H53NO15
Masse moléculaire
Paclitaxel STD-853.91: IMP-A-831.90: IMP-G-811.87: IMP-I-1079.15: IMP-L-895.94
Synonyme

Paclitaxel STD-[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate; Abraxane; Genaxol; Genetaxyl; OncoGel; Onxal; Pacliex; (-)-Paclitaxel; Taxol; Yewtaxan; NSC 125973; Benzenepropanoic acid, B-(benzoylamino)-A-hydroxy-,6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H -cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR -[2aA,4B,4aB,6B,9A( AR*, BS*),11A,12A,12aA,12bA]]; (2aR,4S,4aS ,6R, 9S ,11S,12S,12aR,12bS )-1,2a,3,4,4a,6,9,10,11,12,12a,12b-Dodecahydro-4,6,9,11,12,12b-hexahydroxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca[3,4]-benz[1,2-b]oxet-5-one 6,12b-diacetate,12-benzoate,9-ester with (2R,3S )-N-benzoyl-3-phenylisoserine (USP)

Paclitaxel-IMP-A-[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] (E)-2-methylbut-2-enoate:

Paclitaxel-IMP-G-[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate

Paclitaxel-IMP-I-[(1S,2S,4S,7R,9S,10S,12R,15S)-4-acetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-12-[(2S,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate

Paclitaxel-IMP-L-[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,9,12-triacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate

Slide 1.GIF

Paclitaxel semi-synthetic for System Suitability CRS used to verify the performance of the chromatographic system by evaluating parameters like resolution, repeatability, and retention time during system suitability testing before sample analysis.